å°çã®ãããªçççããã®è§£æŸ
ããïŒãïŒå¹Žã§ç§ã®QOLïŒç掻ã®è³ªïŒã¯ãã£ãšåäžããŸããããããŠããã®å€§ããªèŠå ã®ã²ãšã€ã¯ãã«ã§ããã
ãã«ãšèããšé¿åŠã®ã€ã¡ãŒãžã匷ããããããŸããããããã ãã§ã¯ãããŸããã
åŸã§ãã£ãšè©³ããã話ããŸãããæçµå°é£çã«èŠããã§ããç§ã®ã±ãŒã¹ã§èšããšãçççã®çã¿ãåçã«æžããäœèª¿äžè¯ã®æ¥æ°ãæžããŸããã
åã女æ§ãçŸç¶åŠåš ã®äºå®ããªãïŒãã©å°æ¥åã©ããã»ããïŒå¥³æ§ã«ããã£ãšãã£ãšãã«ã®ã¡ãªãããäŒãã£ãŠã»ããã
ããæã£ãŠãã®æçš¿ãæžããŠããŸãã
Â
æ¥æ¬ã§ã¯ãŸã ãŸã ãã«ã浞éããŠããªã
åœé£ãçºè¡šãããContraceptive Use by Method 2019ãã«ãããšãæ¥æ¬ã§ã¯é¿åŠæ¹æ³ãšããŠïŒå²è¿ããã³ã³ããŒã ãæãããã«ãæãã人ã¯ãã£ãã®2.9%ã
åœé£ãåç §ããŠããå ããŒã¿ã¯2015幎ã®èª¿æ»ã®ãããªã®ã§ãä»ã§ã¯ããå°ãå©çšãã人ãå¢ããŠãããã§ãããããã§ãäœãæ°åã§ãããã
ãšãŒãããåã§ã¯ãã«æçšçã3å²è¿ãåœãå€ãããïŒç¹ã«è¥¿ãšãŒãããïŒããšãéã¿ããšãæ¥æ¬ãã¢ãžã¢åã§ã¯ãŸã ãã«ãããŸã浞éããŠããªãããšã宿ããŸãã
Â
ççã£ãŠå®ã¯æ¯æãªããŠã倧äžå€«
ãã«èªäœã®æµžé床ã®äœãã«å ããŠãããããåºãã£ãŠããªãèªèãããã
ççã£ãŠå®ã¯æ¯æãªããŠã倧äžå€«ãªãã§ãã
ç§ãã¯ãããŠå©Šäººç§ã§å çãããã®è©±ãèããæã«ãã¡ããã¡ãæžæããŸããããåŸã 身äœã«åœ±é¿ãåºãã®ã§ã¯ãšå¿é ã«ãªããŸããã
ãã ãå ã ççã£ãŠåŠåš ã®ããã«ãããã®ã§ãå®ã¯èµ·ãããªããŠã身äœã«æªåœ±é¿ã¯ãªãã®ã ãšãã
ç ç©¶ã§ããæ¯æççãèµ·ããå Žåãšé£ç¶æäžããå Žåãšã§ãè¡æ çã®çºçççã«éãã¯ãªãããåé¡ãªãããšãã倿ã«ãªã£ãŠããŸãã
ãã®ãããªé£ç¶æäžã®ã¡ãªãããšããŠã¯ãæçµã®åæ°ãæžãããšã«ããæçµåãæçµäžã®äœèª¿äžè¯ãåçã«æžããããšããããšã§ãããã«ã¯å¥³æ§ãã«ã¢ã³ã§ãããšã¹ããã²ã³ãšé»äœãã«ã¢ã³ãå ¥ã£ãŠãããâ æåµãæå¶ããâ¡åå®®å èãèãããããšã§ãé¿åŠå¹æãæçµçã®æ¹åãæçµéã®æžå°ãåŸãããŸããããã«æçµã®åæ°èªäœãæžãããšã§æçµåçåçŸ€ïŒæçµåã®ç²Ÿç¥çç¶ã身äœçç¶ïŒãæçµå°é£çïŒæçµäžã®è ¹çã»è °çã»é çãªã©ã®é䌎çç¶ïŒã®çç¶èªäœããªããããšãã§ããã®ã§ãã
ããã«ããããªã«ãã£ãšé£²ãã§å¯äœçšã¯å€§äžå€«ïŒããççãæ°ã«ææ¥ãªããŠå€§äžå€«ïŒããšããå¿é ã«å¯ŸããŠããç ç©¶ã§åé¡ãªãããšãåãã£ãŠããŸãã
ã¢ã¡ãªã«ã§è¡ããããã«84æ¥ãŸãã¯365æ¥é£ç¶æäžçŸ€ãšåŸæ¥ã®21æ¥æäžçŸ€ãæ¯èŒããç ç©¶ã§ã¯ãè¡æ çã®çºççã«ææå·®ããããŸããã§ããïŒ1000人ïŒå¹Žåœãã1.44人 vs 1.09人ïŒïŒLi J, et al:JAMA Intern Med. 2018;178(11):1482-8.ïŒããŸãããã«ãæ¢ããŠããæçµãå埩ããæéã¯å¹³å1ã«æã§åŸæ¥ã®ãã«ãšå·®ããªããé£ç¶å æäžã®è¡å§ã»è質å€åãåŸæ¥çŸ€ãšææå·®ããããŸããã§ããïŒMendoza N, et al:Eur J Contracept Reprod Health Care. 2014;19(5):321-39.ïŒã
ããããåŠåš ã®äºå®ããªãã®ã«æåµãç¶ããããšã¯ãå°æ¥çã«åŠåš åºç£ãèããŠãã人ã«ãšã£ãŠã¯ãªã¹ã¯ã ãšãã話ããããŸãã
æåµãç¶ãããªã¹ã¯ã«ã€ããŠã¯ããã¡ãã®æ¥çµDoorsã®èšäºãèªãã§ã¿ãŠãã ããã
ãé¿åŠã ããããªãããã«ã¯åã女æ§ã®å³æ¹ã
æåµã®æãåµåã¯æ¯æãåµå·£ã®å£ãçªãç Žã£ãŠè ¹è å ã«æŸåºãããŸããå£ãçªãç Žããšããããšã¯ãæ¯æãæåµã¯åµå·£ã«ãã¡ãŒãžãäžããŠãããšããããšããšé«æ©ããã女æ§ãçæ¶¯ã§çãåã©ãã®æ°ãå€ãã£ãæä»£ã«æ¯ã¹ãŠãçŸä»£ã®å¥³æ§ã¯åŠåš ã§ççãæ¢ãŸã£ãŠããæéãçãåããã®ãã¡ãŒãžãå€ãåããŠãããšãããŸãããæã®å¥³æ§ã¯åºç£åæ°ãå€ããçæ¶¯ã®æåµåæ°ãå°ãªãããã®åãåµå·£ã®ãã¡ãŒãžã¯å°ãªãã£ãã®ã§ããçŸä»£ã¯åºç£åæ°ãæžã£ãåãçæ¶¯ã®æåµãæçµã®åæ°ãå¢ããŠãåå®®å èçãåµå·£ãããå¢ããŠããŸããäœçšéãã«ã¯ãæçšããŠããéã¯æåµãæå¶ããŸããæåµã¯åµå·£ã«ãã¡ãŒãžãäžããŸãããåŠåš ããããã«å¿ èŠãªããšããã°ããåºç£ã®äºå®ããªãã®ãªããåµå·£ããã°ããäŒãŸããŠãããã»ãããå°æ¥ã®åŠåš ã®ããã«ã¯ãããã§ããé·æçãªãã«ã®æçšã«ãã£ãŠåŠåš ãããããªããšããæµ·å€ã®è«æããããŸãã
ç§ã®ãã«äœ¿çšæŽã»äœéšè«
ç§ããã«ãå©çšãã¯ãããã®ã¯ã¡ããã©ïŒå¹Žã»ã©åã
åœæã®å®¶ã®è¿ãã«ãã£ã婊人ç§ã«æïŒã§éããïŒå¹ŽåŒ±ã»ã©28æ¥åšæã®ãã«ãã€ãŒãºãã詊ããŸããã
ãã«ã®å¯äœçšã§æãå¿é ãããã®ã¯è¡æ çã§ãããããã«é¢ããŠã¯ã¡ãããšå©Šäººç§ã§æ°ã¶æåŸã«è¡æ¶²æ€æ»ãããŠãããŸããã
è¡æ¶²æ€æ»ãåå®®ç³»ã®æ€èšºçµæã«ãç°åžžãã¿ãããªãã£ãããããã®åŸãå»è ãããšçžè«ããããã§ãççã®åæ°ãæžãããã€ãŒãºãã¬ãã¯ã¹é åé ãã«åãæ¿ãã
ã€ãŒãºãã¬ãã¯ã¹ã®ãµã€ãã®æ å ±ã§ã¯ãæå€§120æ¥éã®é£ç¶æçšå¯èœãšã®ããšã§ãããç§ã¯å©Šäººç§ã®å çããïŒã¶æã«ïŒåãšèšãããŸããã
çŸåšã¯ã¢ã¡ãªã«ã§ããã©ã³ãã¯ç°ãªããã®ã®ãæåãåããã«ïŒLorynaïŒããå»è ããããåŠæ¹ããŠããã£ãŠãïŒã¶æã«ïŒåççãèµ·ããããã«ããŠäœ¿ã£ãŠããŸãã
æ¯æãããªæãã§ãã«ããã©ãã°ã¹ãã¢ã§åãåãã®ã§ãããâOkay to take placebo pills every 3 monthsïŒäŒè¬çšã®ãã©ã»ãåœè¬ã¯ãïŒã¶æã«ïŒåã§OKïŒâãšæžããŠãããŠãŸããã
æå®ã®ãã©ãã°ã¹ãã¢ã«æ¯æè£å ãããã®ã§ãäžåºŠæåã«Zoomã³ãŒã«ã§ãå»è ããã«åŠæ¹ããŠããã£ãåŸã¯ãã¯ãªããã¯ã«ãè¡ãããšããããŸããã
Â
ãã«ã§ççã®åæ°ãæžããããšã§ãå®éã«æããã¡ãªãã
åé ã§ãå°ãè§ŠããŸããããç§ãå®éã«æããããšãã§ããã¡ãªããã¯äžèšã§ãã
æ¯åã®åºè¡éãæžããçççãåçã«ç·©åãä»ã§ã¯çã¿æ¢ãã飲ãã ãšããŠãçç忥ã«ïŒåã ãã§æžãã§ããŸãã
äœèª¿äžè¯ã®æ¥æ°ãæ¿æžããããŸã§PMSãšççãšã§ãæã®ååè¿ãäœããã®äœèª¿äžè¯ã ã£ãã®ããä»ã§ã¯ãPMSããªããšæããäœèª¿äžè¯ãªæ¥ã¯ãæã«æ°æ¥ãããã§ãã
ççãèµ·ããã¿ã€ãã³ã°ãã³ã³ãããŒã«ã§ãããããã£ãŠåã女æ§ãã¢ã¹ãªãŒãã¯ãã¡ããããããã女æ§ã«ã¡ãªãããããã®ã§ã¯ãçççŽåãççæ¥ã¯ã©ãããŠãäœèª¿ã厩ããã®ã§ããã®ã¿ã€ãã³ã°ãéžã¹ãã ãã§ããã®ããããããããã§ããæ è¡ã®äºå®ãããå Žåã¯ããã®æ¥ãé¿ããŠççãèµ·ããããšãã§ããŸãã
- ççãïŒã¶ææ°ã«ããã«æžããããã£ãŠå®ã¯ãããŸããã¡ãªããã§ãããå¿é äºã£ãŠãé ã®äžã«ããã ãã§äœããšç¥çµã䜿ããã®ããäžæ£åºè¡ãèµ·ãããªãéããïŒã¶æã¯ãã®ãŸãŸç¶ããŠå€§äžå€«ããšåãã£ãŠãããšãé ã®äžããççã«é¢ããå¿é ããã°ããæ¶ããã®ã§ãã
- èèãã®æ¹åïŒççã«ããèèããã©ãã«ãæžããŸãããïŒã¶æã«ïŒåããççããªãã®ã§ããã«ã¢ã³ãã©ã³ã¹ã®ä¹±ãã«ãã£ãŠèã«åœ±é¿ãåºãé »åºŠã¯ããªãå°ãªãã§ãã
ãã«ãæçšããŠå®éã«æãããã¡ãªããã广ãæããŠããªãããšãå¿é ããš
ç§ãå®éã«çµéšããããšããå¿é ã«ãªã£ãã®ã¯äžèšã§ãã
- 䜿ãå§ããé ã®ããã¿ãšäžæ£åºè¡ïŒæçšãå§ããéããå»è ãããã説æã¯èããŠããã®ã§ãç¹ã«é©ãã¯ãããŸããã§ãããæ°ã¶æåŸããã¯ç¹ã«æ°ã«ãªããããªå€åã¯èµ·ãããªããªã£ãããã«æããŸãã
- PMSïŒPMSã«é¢ããŠã¯ãçç¶ã軜ããªã£ãæ°ãããŸããããæ£çŽããã¯ããããããŸãããPMSã®åå ã®ã²ãšã€ã¯ãã«ã¢ã³ãã©ã³ã¹ã®ä¹±ããšèšãããŠããããããã«ã¢ã³ãã©ã³ã¹ãæŽããããšã§æ¹åã§ããããªæ°ã¯ããŸãããçŸç¶ççãïŒã¶æã«ïŒåã§ããæ¯ææ°æ¥ã¯ãããPMSåå ããªããšæããçç¶ããããŸãã誰ã詳ãã人æããŠã»ããâŠã
- è¡æ çã®å¿é ïŒè¡æ çã«é¢ããŠã¯ãå¿é ããããããã ä»åŸãç¡èŠããã«ã身äœãé©å®èгå¯ããŠããããšæã£ãŠããŸããã€ãŒãºãã¬ãã¯ã¹å©çšè ã®æ¹ã¯ããã¡ãã®ããŒãžããã²äžåºŠèŠãŠããããšãããããããŸãã
- æéïŒæ¯ææ°ååã®ãéã¯ããããŸããåœããåã§ããç¡æã§ã¯ãããŸãããã€ãŒãºãã¬ãã¯ã¹ãåŠæ¹ããŠããã£ãŠãããšãã¯èšºå¯å«ããŠæã 3ã»4,000åãããããã£ãŠããããšããšã¯ãããåŸãããã¡ãªãããå€§å¹ ã«äžåãã®ã§ãç§ã¯ããã¯ãŸã£ããæ°ã«ãªããŸããã§ããïŒäžå¿ç¡æã§ã¯ãªãã®ã§ãã¡ãªããã«æããŠãããŸãããïŒã
ä»äºã§æ¯åãããŠãã女æ§ã«ãã詊ããŠã»ãã
ãïŒã³ããã¢ã©ãµãŒå¥³åãä»äºã§æ¯åãããçç±
åé ã®ç»åã¯ãç§ãæãããïŒã³ãã®äžéšã§ãã
ã¡ãã£ãšèªãã§ããã ããã°åããããšæããŸãããçççãã°ã£ã¡ãæ¯åãã®äžå ã«ãªã£ãŠããŸããã
ãã«ã¯ç§ã®æäžäž»ã
ä»ã®å¿«é©ãªç掻ãèãããšããã£ãšãã£ãšæ©ãããã«ã«ã€ããŠç¥ã£ãŠããããã£ããªãšæ£çŽæããŸãã
ä»ããåŠåš ã®äºå®ããªãã®ãªããæ ¹æ§è«ã§çççãPMSã«èããå¿ èŠã£ãŠå šç¶ãªãã
ãã«ã®åŠæ¹ãåããŠãšããæ¹ã¯ããå»è ãããšçžè«ãã€ã€ããŸãã¯28æ¥ã®éåžžã®ãã«ããåããŠããã®ãè¯ãããšæããŸãã
ç§ãå®éã«äœ¿ã£ãããšãããã®ã¯ãã€ãŒãºããã€ãŒãºãã¬ãã¯ã¹ããLorynaãã®ïŒçš®é¡ã§ãããä»ã«ãè²ã ãªçš®é¡ãããã®ã§ãã¯ãªããã¯ã«è¡ãããæ¹ã¯äžåºŠäœãéãã®ããªã©èããŠã¿ãã®ãè¯ããããããŸããã
ããã«ã«èå³ã¯ãããã©äžå®ããšããæ¹ã®ã圹ã«ç«ãŠãã°å¹žãã§ãã
Â